name: Microorganism casts:Naric:Pt:Urine sed:Qn:Computer assisted


name: Microorganism casts:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Calcium oxalate monohydrate crystals:PrThr:Pt:Urine sed:Ord:Computer assisted


name: Calcium oxalate monohydrate crystals:Naric:Pt:Urine sed:Qn:Computer assisted


name: Calcium oxalate monohydrate crystals:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Calcium oxalate dihydrate crystals:PrThr:Pt:Urine sed:Ord:Computer assisted


name: Calcium oxalate dihydrate crystals:Naric:Pt:Urine sed:Qn:Computer assisted


name: Calcium oxalate dihydrate crystals:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Triple phosphate crystals:PrThr:Pt:Urine sed:Ord:Computer assisted


name: Triple phosphate crystals:Naric:Pt:Urine sed:Qn:Computer assisted


name: Triple phosphate crystals:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Urate crystals:PrThr:Pt:Urine sed:Ord:Computer assisted


name: Urate crystals:Naric:Pt:Urine sed:Qn:Computer assisted


name: Urate crystals:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Urate crystals.amorphous:Naric:Pt:Urine sed:Qn:Computer assisted


name: Urate crystals.amorphous:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Phosphate crystals.amorphous:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Atypical crystals:PrThr:Pt:Urine sed:Ord:Computer assisted


name: Atypical crystals:Naric:Pt:Urine sed:Qn:Computer assisted


name: Atypical crystals:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Bacilliform bacteria:Naric:Pt:Urine sed:Qn:Automated count


name: Bacilliform bacteria:NCnc:Pt:Urine sed:Qn:Automated count


name: Cocci bacteria:Naric:Pt:Urine sed:Qn:Automated count


name: Cocci bacteria:NCnc:Pt:Urine sed:Qn:Automated count


name: Amorphous sediment:Naric:Pt:Urine sed:Qn:Automated count


name: Amorphous sediment:NCnc:Pt:Urine sed:Qn:Automated count


name: Schistosoma haematobium:PrThr:Pt:Urine sed:Ord:Computer assisted


name: Schistosoma haematobium:Naric:Pt:Urine sed:Qn:Computer assisted


name: Schistosoma haematobium:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Nucleated cells:Naric:Pt:Body fld:Qn:Automated count


name: Urothelial carcinoma gene expression score:Score:Pt:Urine:Qn:Molgen


name: ADAMTS13 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Myeloproliferative neoplasm multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: JAK2 gene exon 12 full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: JAK2 gene exon 14 full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: MPL gene exon 10 full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: ASXL1 gene exon 13 full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: KIT gene exon 17 full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Atypical hemolytic uremic syndrome multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Thrombotic microangiopathy multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: PLG gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Hereditary thrombocytopenia multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hemophagocytic lymphohistiocytosis multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hearing loss multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Methemoglobin & sulfhemoglobin panel:MFr:Pt:Bld:Qn


name: Glomerular filtration rate:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M


name: Kelch-like protein 11 Ab.IgG:PrThr:Pt:Ser:Ord:CBA IFA


name: Tick-borne encephalitis virus Ab.Neut:Titr:Pt:XXX:SemiQn:Neut


name: Hordeum vulgare pollen Ab.IgG4:MCnc:Pt:Ser:Qn


name: Hyaline-granular casts:NCnc:Pt:Urine sed:Qn:Computer assisted


name: Trypanosoma cruzi 160kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Leishmania sp Ab bands panel:-:Pt:Ser:-:IB


name: Bordetella pertussis Ab.IgG panel:-:Pt:Ser:-


name: Schistosoma sp 95kD Ab:PrThr:Pt:Ser:Ord:IB


name: Fasciola sp 8-9kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Speech-language pathology (SLP) related surveys


name: Non-patient incident (not otherwise listed)


name: Initiated primary care and transferred to another EMS crew


name: Provided care supporting primary EMS crew


name: Assumed primary care from another EMS crew


name: Incident support services provided (including standby)


name: Back in service, no care/support services required


name: Back in service, care/support services refused


name: Transport by this EMS unit (this crew only)


name: Transport by this EMS unit, with a member of another crew


name: Transport by another EMS unit, with a member of this crew


name: Non-patient transport (not otherwise listed)


name: I have a skin lesion (spot) or lesions that worry me and I want them checked


name: Problem with rash or follow up on previously treated skin condition.


name: Collected by healthcare professional unsupervised


name: In-person supervision by healthcare professional


name: Virtual supervision by healthcare professional


name: Never drive during the daytime because of vision


name: Never drive during the daytime for other reasons


name: Never drive in these conditions for other reasons


name: Never try to do these activities because of vision


name: Never try to do these activities for other reasons


name: Non-transport-medical treatment (BLS equipped)


name: Non-transport-medical treatment (ALS equipped)


name: Ground transport (critical care equipped)


name: Ventilation-passive ventilation with oxygen


name: Melbourne ambulance stroke screen (MASS)


name: Rapid arterial occlusion evaluation (RACE)


name: Los Angeles prehospital stroke screen (LAPSS)


name: Physical exam indicates suspected alcohol or drug use


name: Yes, but did not affect my normal activities


name: Yes, did affect my normal activities (e.g. walking short distances)


name: Yes, I would decide to have it again, because of my result


name: Yes, I would decide to have it again, despite my result


name: No, I would not decide to have it again, because of my result


name: No, I would not decide to have it again, despite my result


name: Drug and/or alcohol rehabilitation facility


name: Evaluation for special referral/intake programs


name: Non-hospital facility to hospital transfer


name: Non-hospital facility to non-hospital facility transfer


name: Hospital to non-hospital facility transfer


name: Stroke-acute stroke ready hospital (ASRH)


name: Stroke-comprehensive stroke center (CSC)


name: 0 - When I had shortness of breath, it felt very mild


name: 10 - When I had shortness of breath, it felt very severe


name: 0 - When I had shortness of breath, it lasted only for a moment


name: 10 - When I had shortness of breath, it lasted for a very long time


name: You have been able to arrange for some medication refills but not all


name: You are waiting to hear from your physician on how to refill medications


name: Yes, you will be picking up from the pharmacy


name: Yes, someone will be picking up your medications for you


name: Your clinic is closed because of COVID-19


name: You had symptoms of COVID-19, so you stayed home


name: You cancelled the appointment to avoid being around others


name: You cancelled the appointment because you did not want to be in a healthcare setting


name: You didn't want to take public transportation and had no other way to get there


name: You forgot to go/just missed your appointment


name: You felt disrespected by the office or medical staff


name: You couldn't get your medications because the pharmacy closed


name: You couldn't get to the pharmacy because of COVID-19 shutdowns


name: You couldn't get to the pharmacy because you wanted to avoid being around others


name: You felt good, didn't need your medications


name: Your doctor advised you to delay treatment


name: You didn't have money or insurance to get medicine


name: You didn't want to take public transportation to pick up your prescription and had no other way to get there


name: I could not rely on good techncial mans (computer or WiFi)


name: Tried but was not able to apply for, or was not eligible


name: By putting it on my credit card and paying it off in full at the next statement


name: By putting it on my credit card and paying it off over time


name: With the money currently in my checking/savings account or with cash


name: By borrowing from a friend or family member


name: Using a payday loan, deposit advance, or overdraft


name: By asking my landlord or mortgage provider for an extension


name: I wouldn't be able to pay for the expense right now


name: No, my household income is about the same


name: With the aid of glasses to see in the distance


name: With the aid of contact lenses to see in the distance


name: With the aid of contact lenses for reading


name: Don't have changes in the clarity of my vision


name: Yes, but ONLY when NOT wearing glasses or contact lenses


name: Yes, but ONLY when wearing glasses or contact lenses


name: Yes, when wearing AND when not wearing glasses or contacts


name: 0: Eye problem(s) had no effect on my work


name: 0: Eye problem(s) had no effect on my daily activities


name: 10: Eye problem(s) completely prevented me from doing my regular activities


name: I use glasses to correct my vision for distance


name: I use glasses to correct my vision for reading


name: I use soft contact lenses to correct my vision for distance


name: I use soft contact lenses to correct my vision for reading


name: I use hard (rigid gas permeable) contact lenses to correct my vision for distance


name: I use hard (rigid gas permeable) contact lenses to correct my vision for reading


name: So much difficulty that I can no longer do some of my usual activities


name: Discussions with any other eye care professional (e.g., ophthalmologist or optometrist)


name: Discussions with another physician, not an opthalmologist


name: Eye care professional's office pamphlets


name: Discussions with family or friends who have not had LASIK surgery


name: Discussions with family or friends who have had LASIK surgery


name: Unknown Onset (if focal or generalized) - Motor Tonic-clonic


name: Unknown Onset (if focal or generalized) - Other Motor


name: Unknown Onset (if focal or generalized) - Nonmotor


name: Unclassified (i.e., unsure if epileptic or not)


name: Nonepileptic (i.e., psychogenic or physiologic)


name: Innumerable (i.e., >= 10 per day most days)


name: Multiple per day (i.e., 4 days per week with >= 2 seizures)


name: Monthly but not weekly (i.e., 1-3 per month)


name: At least once per year, but not every month (i.e., 10 or fewer in past 12 months)


name: More than 2 years ago (more than 105 weeks ago)


name: Consulted GP/practice nurse over the phone or online


name: Consulted GP/practice nurse face to face


name: Yes, I was in contact with a confirmed/test COVID-19 case


name: Yes, suspected by a doctor but not tested


name: A doctor/nurse or other health professional


name: I stay at home most of the time because of my back.


name: I change position frequently to try to get my back comfortable.


name: I walk more slowly than usual because of my back.


name: Because of my back, I am not doing any jobs that I usually do around the house.


name: Because of my back, I use a handrail to get upstairs.


name: Because of my back, I lie down to rest more often.


name: Because of my back, I have to hold on to something to get out of an easy chair.


name: Because of my back, I try to get other people to do things for me.


name: I get dressed more slowly than usual because of my back.


name: Because of my back, I try not to bend or kneel down.


name: I find it difficult to get out of a chair because of my back.


name: I find it difficulty to turn over in bed because of my back.


name: My appetite is not very good because of my back.


name: I have trouble putting on my sock (or stockings) because of the pain in my back.


name: I can only walk short distances because of my back pain.


name: Because of my back pain, I get dressed with the help of someone else.


name: I sit down for most of the day because of my back.


name: I avoid heavy jobs around the house because of my back.


name: Because of back pain, I am more irritable and bad tempered with people than usual.


name: Because of my back, I go upstairs more slowly than usual.


name: I stay in bed most of the time because of my back.


name: Rarely during athletics or other severe exertion


name: Frequently during athletics or other sever exertion (or incapable of participation)


name: Inconstant and slight during severe exertion


name: Marked on or after walking more than 2 km


name: Yes, it has kept me from medical appointments or getting medications


name: Body temperature higher than 100.4 F or 38.0 C


name: Gone out to a bar, club, or other place where people gather


name: Gone to a friend, neighbor, or relative's residence (that isn't your own)


name: Had visitors such as friends, neighbors, or relatives at your residence


name: Attended a gathering with more than 10 people, such as a reunion, wedding, funeral, birthday party, concert, or religious service


name: Sought care from a hospital or health care facility


name: Remained in your residence at all times, except for essential activities or exercise


name: Shared items like towels or utensils with other people


name: Had close contact (within 6 feet) with people who live with you


name: Had close contact (within 6 feet) with people who don't live with you


name: Washed your hands with soap or used hand sanitizer several times per day


name: Canceled or postponed air travel for work


name: Canceled or postponed air travel for pleasure


name: Canceled or postponed work or school activities


name: Canceled or postponed personal or social activities


name: Avoided contact with people who could be high-risk


name: Stockpiled hand sanitizer or disinfectant wipes


name: Continuous veno-venous hemofiltration (CVVH)


name: Continuous veno-venous hemodialysis (CVVHD)


name: Yes, the quality of my life has gotten a lot worse


name: Yes, the quality of my life has gotten a little bit worse


name: No, the quality of my life has not been affected


name: Yes, the quality of my life has gotten a little bit better


name: Yes, the quality of my life has gotten a lot better


name: Never had any improvement in my vision after LASIK surgery


name: Yes, I would recommend it because of my result


name: Yes, I would recommend it despite my result


name: No, I would not recommend it because of my result


name: No, I would not recommend it despite my result


name: A laptop, chromebook, or desktop computer


name: Other extended family members such as grandparents, aunts and uncles, and cousins.


name: A paid child care provider such as a nanny or au pair


name: A child care facility not located in your home


name: Pain does not occur on a daily basis or there is daily pain lasting less than a day. If the patient has been pain free during the last 4 weeks 1 should be recorded.


name: Pain occurs several times per day. Pain intensity most often returns to zero (e.g. 0 on a numerical rating scale). There are pain free intervals.


name: Pain is continuously present, pain intensity does generally not go back to zero. There are only rare moments without pain, e.g. during sleep.


name: Pain usually lasted for several days, at most for one week


name: Pain usually persisted for more than a week or was continuous


name: Fluctuation of 2 or more points on a ten point numerical rating scale, two or more times per week


name: Fluctuation of 2 or more points on a ten point numerical scale, less than twice per week


name: Pain intensity does not change or hardly changes


name: Intensity of pain episodes usually varied more than 2 points on a ten point numerical scale. Definition of usually: intensity changed in 50 or more percent of the episodes.


name: Intensity of pain episodes rarely varied 2 points on a ten point numerical scale. Definition of rarely: intensity changed in less than 50% of the pain episodes.


name: Patient complains about one pain in one or more body areas, he or she feels, however, these pain areas belong together.


name: Patient complains about 2 definable pains located in one or more areas of the body.


name: Patient complains about more than two definable pains or his pain areas covers more than 50% of his body surface.


name: No drugs or group I-drug-intake on less than 15 days in the last 4 weeks.


name: Up to maximally 2 drugs of group I on more than 15 days in the last 4 weeks.


name: More than 2 drugs of group I or one or more drugs of group II or III on at least 15 days in the last 4 weeks.


name: No drug withdrawal treatment or significant dose reduction in the past history.


name: One account of drug withdrawal or one attempt of dose reduction in the past history.


name: Two or more drug withdrawals or several dose reduction attempts in the past history.


name: No change of personal, pain managing physician


name: Maximum three changes of personal, pain managing physician


name: More than three changes of personal, pain managing physician


name: No or one pain related hospitalization (for diagnosis and/or treatment)


name: Two to three pain related hospitalizations


name: More than three pain related hospitalizations


name: No or one pain related surgical procedure


name: Two to three pain related surgical procedures


name: More than three pain related surgical procedures


name: No pain related stay in a rehabilitation or pain center


name: One or two pain related stays in a rehabilitation or pain center


name: More than two pain related stays in a rehabilitation or pain center


name: Never drive in these conditions because of vision


name: Your clinic cancelled your appointment because of COVID-19


name: Distance learning was not organized at the school


name: 10: Eye problem(s) completely prevented me from working


name: Weekly but not daily (i.e., 1-3 per week)


name: Yes, I was in contact with a suspected COVID-19 case


name: My back is painful almost all of the time.


name: Marked on or after walking less than 2 km


name: Avoided public spaces, gatherings or crowds


name: Continuous veno-venous hemodiafiltration (CVVHDF)


name: Never had any post-operative symptoms of discomfort after LASIK surgery


name: I want a general skin exam to check for skin cancer. I have no specific areas of concern.


name: Stroke-thrombectomy-capable stroke center (TSC)


name: Perioperative nursing data set outcomes panel:-:Pt:^Patient:-:PNDS


name: Axis I: Temporal aspects score:Score:Pt:^Patient:Qn:Mainz Pain Staging System


name: Axis II: Spatial aspects score:Score:Pt:^Patient:Qn:Mainz Pain Staging System


name: Axis III: Drug taking behavior score:Score:Pt:^Patient:Qn:Mainz Pain Staging System


name: Axis IV: Utilization of the health care system score:Score:Pt:^Patient:Qn:Mainz Pain Staging System


name: Patient contact disposition:Type:Pt:EMS unit:Nom


name: Patient evaluation disposition:Type:Pt:EMS unit:Nom


name: Crew disposition for patient care:Type:Pt:EMS unit:Nom


name: Patient transport disposition:Type:Pt:EMS unit:Nom


name: Prism base direction intermediate:Angle:Pt:Eye.right:Qn:Phoropter


name: Prism base direction intermediate:Angle:Pt:Eye.left:Qn:Phoropter


name: Visual acuity intermediate testing condition:Type:Pt:Eye:Nom:Phoropter


name: Contrast ratio for intermediate visual acuity measurement:NFr:Pt:Eye:Qn:Phoropter


name: Visual acuity.binocular near^best corrected:LenRto:Pt:Eye:Qn


name: Visual acuity.binocular far^best corrected:LenRto:Pt:Eye:Qn


name: Nerve conduction study panel:-:Pt:Nerve:-


name: Sensory nerve conduction panel:-:Pt:Radial nerve.left:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Radial nerve.left:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Radial nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Radial nerve.left:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Radial nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Radial nerve.right:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Radial nerve.right:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Radial nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Radial nerve.right:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Radial nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Median nerve.left:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Median nerve.left:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Median nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Median nerve.left:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Median nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Median nerve.right:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Median nerve.right:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Median nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Median nerve.right:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Median nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Ulnar nerve.left:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Ulnar nerve.left:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Ulnar nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Ulnar nerve.left:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Ulnar nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Ulnar nerve.right:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Ulnar nerve.right:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Ulnar nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Ulnar nerve.right:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Ulnar nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Medial antebrachial cutaneous nerve.left:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Medial antebrachial cutaneous nerve.left:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Medial antebrachial cutaneous nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Medial antebrachial cutaneous nerve.left:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Medial antebrachial cutaneous nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Medial antebrachial cutaneous nerve.right:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Medial antebrachial cutaneous nerve.right:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Medial antebrachial cutaneous nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Medial antebrachial cutaneous nerve.right:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Medial antebrachial cutaneous nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Lateral antebrachial cutaneous nerve.left:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Lateral antebrachial cutaneous nerve.left:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Lateral antebrachial cutaneous nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Lateral antebrachial cutaneous nerve.left:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Lateral antebrachial cutaneous nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Lateral antebrachial cutaneous nerve.right:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Lateral antebrachial cutaneous nerve.right:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Lateral antebrachial cutaneous nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Lateral antebrachial cutaneous nerve.right:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Lateral antebrachial cutaneous nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Sural nerve.left:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Sural nerve.left:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Sural nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Sural nerve.left:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Sural nerve.left:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Sural nerve.right:-


name: Sensory nerve action potential amplitude:Elpot:Pt:Sural nerve.right:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Sural nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Sural nerve.right:Qn:Nerve conduction


name: Sensory nerve action potential area:TmElpot:Pt:Sural nerve.right:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Median nerve.left:-


name: Peak motor nerve conduction latency:Time:Pt:Median nerve.left:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Median nerve.left:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Median nerve.right:-


name: Peak motor nerve conduction latency:Time:Pt:Median nerve.right:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Median nerve.right:Qn:Nerve conduction


name: Nerve segment where motor conduction velocity measured:Anat:Pt:Nerve:Nom


name: Compound muscle action potential area:TmElpot:Pt:Muscle:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Ulnar nerve.left:-


name: Peak motor nerve conduction latency:Time:Pt:Ulnar nerve.left:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Ulnar nerve.left:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Ulnar nerve.right:-


name: Peak motor nerve conduction latency:Time:Pt:Ulnar nerve.right:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Ulnar nerve.right:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Fibular nerve.left:-


name: Peak motor nerve conduction latency:Time:Pt:Fibular nerve.left:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Fibular nerve.left:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Fibular nerve.right:-


name: Peak motor nerve conduction latency:Time:Pt:Fibular nerve.right:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Fibular nerve.right:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Tibial nerve.left:-


name: Peak motor nerve conduction latency:Time:Pt:Tibial nerve.left:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Tibial nerve.left:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Tibial nerve.right:-


name: Peak motor nerve conduction latency:Time:Pt:Tibial nerve.right:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Tibial nerve.right:Qn:Nerve conduction


name: Sensory nerve conduction panel:-:Pt:Nerve:-


name: Distance from nerve stimulation to recording site:Len:Pt:Nerve:Qn


name: Sensory nerve action potential amplitude:Elpot:Pt:Nerve:Qn:Nerve conduction


name: Peak sensory nerve conduction latency:Time:Pt:Nerve:Qn:Nerve conduction


name: Sensory nerve conduction velocity:Vel:Pt:Nerve:Qn:Nerve conduction


name: Nerve segment where sensory conduction velocity measured:Anat:Pt:Nerve:Nom


name: Sensory nerve action potential area:TmElpot:Pt:Nerve:Qn:Nerve conduction


name: Motor nerve conduction panel:-:Pt:Nerve:-


name: F-wave motor nerve conduction panel:-:Pt:Nerve:-


name: Minimum F-wave latency:Time:Pt:Nerve:Qn:Nerve conduction


name: Repetitive motor nerve stimulation panel:-:Pt:Nerve:-


name: Muscle state at time of nerve stimulation:Find:Pt:Muscle:Nom


name: Compound muscle action potential amplitude:Elpot:Pt:Muscle:Qn:Nerve conduction


name: Percent change in action potential amplitude^post repetitive stimulation:Ratio:Pt:Muscle:Qn


name: Percent change in action potential area^post repetitive stimulation:Ratio:Pt:Muscle:Qn


name: Spontaneous activity.positive sharp waves:Find:Pt:Muscle:Ord:EMG


name: Peak motor nerve conduction latency:Time:Pt:Nerve:Qn:Nerve conduction


name: Motor nerve conduction velocity:Vel:Pt:Nerve:Qn:Nerve conduction


name: Accommodative convergence to accommodation ratio:Type:Pt:Eye:Nom:Phoropter


name: Accommodative convergence to accommodation ratio:Ratio:Pt:Eye:Qn:Phoropter


name: Lens used for testing:InvLen:Pt:Eye:Qn:Phoropter


name: Prism for far phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Prism for far phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Prism base direction for far phoria:Angle:Pt:Eye.right:Qn:Phoropter


name: Prism base direction for far phoria:Angle:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.out for far phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.out for far phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.in for far phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.in for far phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Vertical prism.up for far phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Vertical prism.up for far phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Vertical prism.down for far phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Vertical prism.down for far phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Prism for near phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Prism for near phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Prism base direction for near phoria:Angle:Pt:Eye.right:Qn:Phoropter


name: Prism base direction for near phoria:Angle:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.out for near phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.out for near phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.in for near phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.in for near phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Vertical prism.up for near phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Vertical prism.up for near phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Vertical prism.down for near phoria:InvLen:Pt:Eye.right:Qn:Phoropter


name: Vertical prism.down for near phoria:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.in far for Sheard:InvLen:Pt:Eye:Qn:Phoropter


name: Horizontal prism.out far for Sheard:InvLen:Pt:Eye:Qn:Phoropter


name: Sphere far for Sheard:InvLen:Pt:Eye:Qn:Phoropter


name: Horizontal prism.in near for Sheard:InvLen:Pt:Eye:Qn:Phoropter


name: Horizontal prism.out near for Sheard:InvLen:Pt:Eye:Qn:Phoropter


name: Sphere near for Sheard:InvLen:Pt:Eye:Qn:Phoropter


name: Horizontal prism.in far for Percival:InvLen:Pt:Eye:Qn:Phoropter


name: Horizontal prism.out far for Percival:InvLen:Pt:Eye:Qn:Phoropter


name: Sphere far for Percival:InvLen:Pt:Eye:Qn:Phoropter


name: Horizontal prism.in near for Percival:InvLen:Pt:Eye:Qn:Phoropter


name: Horizontal prism.out near for Percival:InvLen:Pt:Eye:Qn:Phoropter


name: Sphere near for Percival:InvLen:Pt:Eye:Qn:Phoropter


name: Add for monocular accommodative lag:InvLen:Pt:Eye.right:Qn:Phoropter


name: Add for monocular accommodative lag:InvLen:Pt:Eye.left:Qn:Phoropter


name: Add for binocular accommodative lag:InvLen:Pt:Eye.right:Qn:Phoropter


name: Add for binocular accommodative lag:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.out for monocular accommodative lag:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.out for monocular accommodative lag:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.in for monocular accommodative lag:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.in for monocular accommodative lag:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.in for binocular accommodative lag:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.in for binocular accommodative lag:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.out for binocular accommodative lag:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.out for binocular accommodative lag:InvLen:Pt:Eye.left:Qn:Phoropter


name: Meter angle for near point convergence:Arb:Pt:Eye:Qn:Phoropter


name: Prism for near point convergence:InvLen:Pt:Eye:Qn:Phoropter


name: Prism for near point accommodation:InvLen:Pt:Eye.right:Qn:Phoropter


name: Prism for near point accommodation:InvLen:Pt:Eye.left:Qn:Phoropter


name: Prism for near point accommodation:InvLen:Pt:Eye:Qn:Phoropter


name: Prism for far fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Prism for far fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Prism base direction for far fixation disparity:Angle:Pt:Eye.right:Qn:Phoropter


name: Prism base direction for far fixation disparity:Angle:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.out for far fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.out for far fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.in for far fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.in for far fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Vertical prism.up for far fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Vertical prism.up for far fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Vertical prism.down for far fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Vertical prism.down for far fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Prism for near fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Prism for near fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Prism base direction for near fixation disparity:Angle:Pt:Eye.right:Qn:Phoropter


name: Prism base direction for near fixation disparity:Angle:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.out for near fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.out for near fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Horizontal prism.in for near fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Horizontal prism.in for near fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Vertical prism.up for near fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Vertical prism.up for near fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Vertical prism.down for near fixation disparity:InvLen:Pt:Eye.right:Qn:Phoropter


name: Vertical prism.down for near fixation disparity:InvLen:Pt:Eye.left:Qn:Phoropter


name: Threshold angle for measuring depth perception:Angle:Pt:Eye:Qn:Phoropter


name: Accommodation using minus lens:InvLen:Pt:Eye:Qn:Phoropter


name: Urothelial carcinoma probability score:Score:Pt:Urine:Qn:Based on clinical+lab data


name: Cardiac stress EKG study:Find:Pt:^Patient:Doc


name: Esophageal pH monitoring study:Find:Pt:^Patient:Doc


name: Views abduction + internal rotation:Find:Pt:Pelvis & Lower extremity.left>Hip:Doc:XR


name: Views abduction + internal rotation:Find:Pt:Pelvis & Lower extremity.right>Hip:Doc:XR


name: View pronated oblique:Find:Pt:Upper extremity.right>Wrist:Doc:XR


name: View pronated oblique:Find:Pt:Upper extremity.left>Wrist:Doc:XR


name: Room brightness level during testing:Type:Pt:Eye:Nom


name: Negative relative accommodation blur:InvLen:Pt:Eye:Qn:Phoropter


name: Positive relative accommodation blur:InvLen:Pt:Eye:Qn:Phoropter


name: Negative relative accommodation recovery:InvLen:Pt:Eye:Qn:Phoropter


name: Positive relative accommodation recovery:InvLen:Pt:Eye:Qn:Phoropter


name: Knee injury and osteoarthritis outcome score - physical function shortform panel:-:Pt:^Patient:-:KOOS-PS


name: WHO Quality of life-BREF:-:2W:^Patient:-:WHOQOL_BREF


name: Hip disability and osteoarthritis outcome score - physical function shortform panel:-:Pt:^Patient:-:HOOS-PS


name: Reduced nutritional intake in last W:Find:1W:^Patient:Ord


name: Children's HealthWatch Housing Stability Vital Sign:-:RptPeriod:^Patient:-:HSVS


name: Cardiovascular disease 10Y risk:Likelihood:Pt:^Patient:Qn


name: Outcome and assessment information set (OASIS) form - version E:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E - Start of Care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Administrative information - SOC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Hearing, speech, and vision - SOC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Cognitive Patterns - SOC, ROC, DC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Health Conditions - SOC, ROC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Special Treatment, Procedures, and Programs - SOC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Behavior - SOC, ROC, DC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Active Diagnoses - SOC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Preferences for Customary Routine Activities - SOC, ROC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Functional Status - SOC, ROC, DC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Self-care - follow-up performance:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Mobility - follow-up performance:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Medications - SOC, ROC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Swallowing And Or Nutritional Status - SOC:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E - Follow Up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Functional abilities and goals - FU:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Functional Status - follow up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Health Conditions - FU:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Skin Conditions - FU:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E - Death at Home:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Administrative information - DAH:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E - Resumption of Care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Administrative information - ROC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Active Diagnoses - ROC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Health Conditions - DC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Swallowing And Or Nutritional Status - ROC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Special Treatment, Procedures, and Programs - ROC:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E - Transfer to an Inpatient Facility:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Administrative information - TRN:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Special Treatment, Procedures, and Programs - transfer to an inpatient facility:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Participation in Assessment and Goal Setting - TRN, DC:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version E - Discharge from Agency:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Administrative information - DC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Swallowing And Or Nutritional Status - DC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Skin Conditions - DC:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Special Treatment, Procedures, and Programs - discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Medications - DC:-:RptPeriod:^Patient:-:CMS Assessment


name: Patient-reported outcomes with LASIK - pre-operative panel:-:Pt:^Patient:-:PROWL


name: H missed from work because of eye problems in past 7D:Time:7D:^Patient:Qn


name: FDA-initiated compliance action drug registration and listing inactivation - animal drug:-:-:^FDA product label:Nar


name: Tegner activity scale panel:-:Pt:^Patient:-:Tegner


name: Provision of current reconciled medication list to subsequent provider at transfer:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Checklist of nonverbal pain indicators panel:-:Pt:^Patient:-:CNPI


name: Checklist of nonverbal pain indicators with movement panel:-:Pt:^Patient:-:CNPI


name: Checklist of nonverbal pain indicators at rest panel:-:Pt:^Patient:-:CNPI


name: Checklist of nonverbal pain indicators assessment:Imp:Pt:^Patient:Nom:CNPI


name: Total score^^adjusted for age:Score:Pt:^Patient:Qn


name: OASIS E - Intervention synopsis - DC, TRN:-:RptPeriod:^Patient:-:CMS Assessment


name: Shared decision making panel:-:Pt:^Patient:-:R-Outcomes


name: Shared decision making total score:Score:Pt:^Patient:Qn:R-Outcomes


name: Cardiac loop monitor study:Find:Stdy:Heart:Doc


name: History and physical note:Find:Pt:{Setting}:Doc:Solid organ transplant


name: History and physical note:Find:Pt:{Setting}:Doc:Thromboembolism


name: History and physical note:Find:Pt:{Setting}:Doc:Obstetrics.midwife


name: History and physical note:Find:Pt:{Setting}:Doc:Maternal and fetal medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Gynecologic oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Family medicine


name: Discharge summary note:Find:Pt:{Setting}:Doc:Colon and rectal surgery


name: Discharge summary note:Find:Pt:{Setting}:Doc:Thoracic and cardiac surgery


name: Discharge summary note:Find:Pt:{Setting}:Doc:Family medicine


name: Evaluation note:Find:Pt:Emergency department:Doc:Geriatric medicine


name: View Judet external oblique:Find:Pt:Lower extremity.right>Hip:Doc:XR


name: View Judet external oblique:Find:Pt:Lower extremity.left>Hip:Doc:XR


name: View Judet internal oblique:Find:Pt:Lower extremity.left>Hip:Doc:XR


name: View Judet internal oblique:Find:Pt:Lower extremity.right>Hip:Doc:XR


name: Behavior change total score:Score:Pt:^Patient:Qn:R-Outcomes


name: Acceptance of loss panel:-:Pt:^Patient:-:R-Outcomes


name: Acceptance of loss total score:Score:Pt:^Patient:Qn:R-Outcomes


name: Roland Morris Disability Questionnaire panel:-:Pt:^Patient:-:RMDQ


name: Columbia Behavior Scale for Dementia panel:-:Pt:^Patient:-:CBS-8


name: Motor disinhibition factor score:Score:Pt:^Patient:Qn:CBS-8


name: Lysholm Knee Scoring Scale:-:Pt:^Patient:-:LKSS


name: Multisection for venous mapping:Find:Pt:Lower extremity.left>Lower extremity vein:Doc:US.doppler


name: Multisection for venous mapping:Find:Pt:Lower extremity.right>Lower extremity vein:Doc:US.doppler


name: Multisection for venous mapping:Find:Pt:Lower extremity.bilateral>Lower extremity vein:Doc:US.doppler


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Subclavian vessels.bilateral:Doc:MR.angio


name: Multisection^WO contrast:Find:Pt:Abdomen>Abdominal vessels & Pelvis>Pelvis vessels:Doc:MR.angio


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Heart:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Neck+Chest+Abdomen+Pelvis:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Temporomandibular joint:Doc:CT.cone beam


name: Atrial electrical activity captured:Find:Pt:Pacemaker:Ord


name: Atrial electrical activity sensed:Find:Pt:Pacemaker:Ord


name: Post-ventricular atrial refractory period setting:Time:Pt:Pacemaker:Qn


name: Ventricular electrical activity captured:Find:Pt:Pacemaker:Ord


name: Ventricular electrical activity sensed:Find:Pt:Pacemaker:Ord


name: Multisection for stroke mapping:Find:Pt:Head>Brain:Doc:MR


name: Multisection for seizure mapping:Find:Pt:Head>Brain:Doc:MR


name: Continuous renal replacement therapy mode:Type:Pt:Renal replacement therapy circuit:Nom


name: Continuous renal replacement therapy fluid removal goal:Vol:1H:^Patient:Qn


name: Venous lumen volume:Vol:Pt:Dialysis catheter:Qn


name: Blood flow rate:VRat:Pt:Renal replacement therapy circuit:Qn


name: Dialysate flow rate:VRat:Pt:Renal replacement therapy circuit:Qn


name: Post-filter replacement fluid rate:VRat:Pt:Renal replacement therapy circuit:Qn


name: Pre-filter replacement fluid rate:VRat:Pt:Renal replacement therapy circuit:Qn


name: Access pressure:Pres:Pt:Renal replacement therapy circuit:Qn


name: Effluent pressure:Pres:Pt:Renal replacement therapy circuit:Qn


name: Filter pressure:Pres:Pt:Renal replacement therapy circuit:Qn


name: Transmembrane pressure:Pres:Pt:Renal replacement therapy circuit:Qn


name: Return pressure:Pres:Pt:Renal replacement therapy circuit:Qn


name: Medication added to peritoneal dialysis fluid:Vol:Pt:Medication:Qn


name: Peritoneal dialysis fluid infused:Vol:Pt:^Patient:Qn


name: Peritoneal dialysis fluid drained:Vol:Pt:^Patient:Qn


name: Pressure drop:PressDiff:Pt:Renal replacement therapy circuit:Qn


name: Dialysate fluid:Type:Pt:Renal replacement therapy circuit:Nom


name: Replacement fluid:Type:Pt:Renal replacement therapy circuit:Nom


name: Arterial lumen volume:Vol:Pt:Dialysis catheter:Qn


name: Reason for filter change:Find:Pt:Renal replacement therapy circuit:Nom


name: Hemodialysis fluid removal goal:Vol:Procedure dur:^Patient:Qn


name: Hemodialysis fluid removed:Vol:Procedure dur:^Patient:Qn


name: Patient reported outcomes with LASIK - post-operative panel:-:Pt:^Patient:-:PROWL


name: Negative predictive value:Likelihood:Pt:Laboratory device:Qn


name: Positive predictive value:Likelihood:Pt:Laboratory device:Qn


name: Functional Communication Measure - Cognition ages 6 or older panel:-:Pt:^Patient:-:ASHA NOMS


name: Functional Communication Measure - Cognition ages 6 or older score:Score:Pt:^Patient:Qn:ASHA NOMS


name: Name of the household member in grade 12:Find:Pt:^Household member:Nom


name: Plans for after high school:Find:Pt:^Household member:Nom


name: Post high school plans changed due to condition of interest or school closures:Find:Pt:^Household member:Ord


name: Previous plans for after high school:Find:Pt:^Household member:Nom


name: Functional Communication Measure - Multi-Modal Functional Communication panel:-:Pt:^Patient:-:ASHA NOMS


name: Functional Communication Measure - Multi-Modal Functional Communication score:Score:Pt:^Patient:Qn:ASHA NOMS


name: Functional Communication Measure - Spoken Language Comprehension ages 6 or older panel:-:Pt:^Patient:-:ASHA NOMS


name: Functional Communication Measure - Spoken Language Comprehension ages 6 or older score:Score:-:^Patient:Qn:ASHA NOMS


name: Functional Communication Measure - Spoken Language Expression ages 6 or older panel:-:Pt:^Patient:-:ASHA NOMS


name: Functional Communication Measure - Spoken Language Expression ages 6 or older score:Score:Pt:^Patient:Qn:ASHA NOMS


name: Functional Communication Measure - Swallowing panel:-:Pt:^Patient:-:ASHA NOMS


name: Functional Communication Measure - Swallowing score:Score:Pt:^Patient:Qn:ASHA NOMS


name: Mainz pain staging system panel:-:Pt:^Patient:-:Mainz Pain Staging System


name: Total score:Score:Pt:^Patient:Qn:Mainz Pain Staging System


name: US.doppler|Lower extremity vein|Multisection for venous mapping|Laterality:ANY


name: XR|Hip|View Judet external oblique|Laterality:ANY


name: XR|Hip|View Judet internal oblique|Laterality:ANY


name: Visual acuity.binocular far^best corrected


name: Visual acuity.binocular near^best corrected


name: Percent change in action potential area^post repetitive stimulation


name: Percent change in action potential amplitude^post repetitive stimulation


name: SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells^^corrected for background


name: SARS coronavirus 2 stimulated gamma interferon release by lymphocytes^^corrected for background


name: Percent neutralization by SARS-CoV-2 (COVID-19) spike protein receptor binding domain (RBD)


name: Anaplasma phagocytophilum & Babesia microti & Ehrlichia chaffeensis Ab.IgG panel


name: Cell-free DNA.donor/Cell-free DNA.total post lung transplant


name: Cell-free DNA.donor/Cell-free DNA.total post cardiac transplant


name: Cell-free DNA.donor/Cell-free DNA.total post kidney transplant


name: SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count^^corrected for background


name: SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count^^corrected for background


name: Surrogate virus neutralization test (sVNT)


name: KOOS-Physical Function Shortform (KOOS-PS)


name: Creatinine and Cystatin C-based formula (CKD-EPI 2021)


name: American Speech-Language-Hearing Association (ASHA) National Outcomes Measurement System (NOMS)


name: Clostridioides difficile toxin Ab.Neut | Serum | Microbiology


name: Escherichia coli verotoxin 1 Ab.Neut | Stool | Microbiology


name: Escherichia coli verotoxin 2 Ab.Neut | Stool | Microbiology


name: Treponema pallidum Ab.IgG bands | Cerebral spinal fluid | Microbiology


name: Treponema pallidum Ab.IgG bands | Serum | Microbiology


name: SARS-CoV-2 (COVID-19) RdRp gene mutation detected | XXX | Microbiology


name: Percent neutralization by SARS-CoV-2 (COVID-19) spike protein receptor binding domain (RBD) neutralizing antibody | Serum or Plasma | Microbiology


name: SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count | Blood | Microbiology


name: SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count | Blood | Microbiology


name: SARS coronavirus 2 stimulated gamma interferon release by lymphocytes | Blood | Microbiology


name: SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells | Blood | Microbiology


name: Bordetella pertussis Ab.IgG panel | Serum | Microbiology Panels


name: Campylobacter sp Ab panel | Serum | Microbiology Panels


name: Chlamydia trachomatis Ab panel | Serum | Microbiology Panels


name: Chlamydophila pneumoniae Ab panel | Serum | Microbiology Panels


name: Chlamydophila psittaci Ab panel | Serum | Microbiology Panels


name: Coxsackievirus B neutralizing Ab panel | Serum | Microbiology Panels


name: Cryptococcus sp Ag panel | Serum | Microbiology Panels


name: Fasciola sp Ab bands panel | Serum | Microbiology Panels


name: Filaria IgG and IgM panel | Serum | Microbiology Panels


name: Helicobacter pylori Ab panel | Serum | Microbiology Panels


name: Leishmania sp Ab bands panel | Serum | Microbiology Panels


name: Leptospira sp Ab panel | Serum | Microbiology Panels


name: Polio virus neutralizing Ab panel | Serum | Microbiology Panels


name: SARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel | Blood | Microbiology Panels


name: Schistosoma sp Ab bands panel | Serum | Microbiology Panels


name: Taenia solium larva Ab bands panel | Serum | Microbiology Panels


name: Toxoplasma gondii Ab bands panel | Serum | Microbiology Panels


name: Trypanosoma cruzi Ab bands panel | Serum | Microbiology Panels


name: Urinary tract pathogens panel | Urine | Microbiology Panels


name: Multidrug resistant gram-negative organism classification | Isolate | Antibiotic susceptibilities


name: Trienoate/Arachidonate | RBC.lysate | Chemistry - non-challenge


name: Cholesterol.esterified actual/normal | Fibroblast | Chemistry - non-challenge


name: 6-oxo-piperidine-2-carboxylate/Creatinine | Urine | Chemistry - non-challenge


name: 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine | Urine | Chemistry - non-challenge


name: n-Acetylglycine/Creatinine | Urine | Chemistry - non-challenge


name: Amyloid beta 42 peptide/Amyloid beta 40 peptide | Cerebral spinal fluid | Chemistry - non-challenge


name: Alpha-1-Acid glycoprotein/Protein.total | Serum or Plasma | Chemistry - non-challenge


name: Alpha 1 antitrypsin/Protein.total | Serum or Plasma | Chemistry - non-challenge


name: Transferrin/Protein.total | Serum or Plasma | Chemistry - non-challenge


name: Protein.monoclonal band 1/Protein.total | Urine | Chemistry - non-challenge


name: Acid alpha glucosidase cross-reactive immunologic material (CRIM) | Tiss | Chemistry - non-challenge


name: Acid alpha glucosidase cross-reactive immunologic material (CRIM) | White blood cells | Chemistry - non-challenge


name: Calcium/Creatinine | Fetus | Chemistry - non-challenge


name: Calcium/Creatinine | Fetus | Urine | Chemistry - non-challenge


name: Choriogonadotropin.tumor marker | Aspirate | Chemistry - non-challenge


name: Choriogonadotropin.tumor marker | Pleural fluid | Chemistry - non-challenge


name: Alzheimer's disease risk | Cerebral spinal fluid | Chemistry - non-challenge


name: 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel | Urine and Serum or Plasma | Chemistry Panels


name: Choriogonadotropin.beta subunit heterophile Ab interference panel | Serum | Chemistry Panels


name: Gas and electrolytes panel | Blood arterial | Chemistry Panels


name: Methemoglobin and sulfhemoglobin panel | Blood | Chemistry Panels


name: Eutylone/Creatinine | Urine | Drug toxicology


name: Sertraline/Creatinine | Urine | Drug toxicology


name: traZODone/Creatinine | Urine | Drug toxicology


name: carBAMazepine and metabolites panel | Serum or Plasma | Drug and Toxicology Panels


name: Stimulants drug panel | Urine | Drug and Toxicology Panels


name: Neutrophils.immature/Neutrophils.segmented | Bone marrow | Hematology and Cell counts


name: Manual differential comment | Bronchoalveolar lavage | Hematology and Cell counts


name: Cells Counted Total | Bronchoalveolar lavage | Hematology and Cell counts


name: Haptoglobin/Protein.total | Serum or Plasma | Hematology and Cell counts


name: Hemoglobinopathy panel | Patient | Hematology and Cell Count Panels


name: Hemolytic anemia panel | Patient | Hematology and Cell Count Panels


name: Osmotic fragility panel | Red Blood Cells | Hematology and Cell Count Panels


name: Red blood cell membrane evaluation panel | Red Blood Cells | Hematology and Cell Count Panels


name: Siderocytes panel | Blood or Marrow | Hematology and Cell Count Panels


name: Clot angle.kaolin induced | Blood | Coagulation


name: ADAMTS13 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: ALK gene targeted mutation analysis | Blood or Tissue | Mutations


name: ASXL1 gene exon 13 full mutation analysis | Blood or Tissue | Molecular pathology


name: BIRC3 gene targeted mutation analysis | Blood or Tissue | Mutations


name: DHCR7 gene full mutation analysis | Blood or Tissue | Mutations


name: FBXW7 gene targeted mutation analysis | Blood or Tissue | Mutations


name: FLT3 gene.p.Asp835+Ile836 mutations/normal | Blood or Tissue | Molecular pathology


name: GNA11 gene targeted mutation analysis | Blood or Tissue | Mutations


name: GNAQ gene targeted mutation analysis | Blood or Tissue | Mutations


name: IDH1 gene targeted mutation analysis | Blood or Tissue | Mutations


name: IDH2 gene targeted mutation analysis | Blood or Tissue | Mutations


name: JAK2 gene exon 12 full mutation analysis | Blood or Tissue | Molecular pathology


name: JAK2 gene exon 14 full mutation analysis | Blood or Tissue | Molecular pathology


name: KCNN4 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: KIT gene exon 17 full mutation analysis | Blood or Tissue | Molecular pathology


name: MET gene targeted mutation analysis | Blood or Tissue | Mutations


name: MPL gene exon 10 full mutation analysis | Blood or Tissue | Molecular pathology


name: NOTCH1 gene targeted mutation analysis | Blood or Tissue | Mutations


name: PLCG2 gene targeted mutation analysis | Blood or Tissue | Mutations


name: PLG gene full mutation analysis | Blood or Tissue | Molecular pathology


name: SETBP1 gene targeted mutation analysis | Blood or Tissue | Mutations


name: SF3B1 gene targeted mutation analysis | Blood or Tissue | Mutations


name: SLC12A1 gene full mutation analysis | Blood | Mutations


name: SMAD4 gene targeted mutation analysis | Blood or Tissue | Mutations


name: SRSF2 gene targeted mutation analysis | Blood or Tissue | Mutations


name: Atypical hemolytic uremic syndrome multigene analysis | Blood or Tissue | Molecular pathology


name: Cancer related multigene analysis | Blood or Tissue | Molecular pathology


name: Cancer related multigene analysis | Plasma cell-free DNA | Molecular pathology


name: Hearing loss multigene analysis | Blood or Tissue | Molecular pathology


name: Hemophagocytic lymphohistiocytosis multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary thrombocytopenia multigene analysis | Blood or Tissue | Molecular pathology


name: Myeloproliferative neoplasm multigene analysis | Blood or Tissue | Molecular pathology


name: Thrombotic microangiopathy multigene analysis | Blood or Tissue | Molecular pathology


name: Cell-free DNA.donor/Cell-free DNA.total | Plasma cell-free DNA | Molecular pathology


name: Hepatocellular carcinoma screening | Patient | Molecular pathology


name: Urothelial carcinoma gene expression score | Urine | Molecular pathology


name: Circumference | Aortic valve | Pathology


name: Circumference | Heart valve XXX | Pathology


name: Circumference | Lower extremity | Pathology


name: Circumference | Mitral valve | Pathology


name: Circumference | Pulmonary valve | Pathology


name: Depth of myometrial invasion/Myometrial thickness | Endometrial cancer specimen | Pathology


name: Stenosis degree | Distal left anterior descending artery | Pathology


name: Stenosis degree | Distal left circumflex artery | Pathology


name: Stenosis degree | Distal right coronary artery | Pathology


name: Stenosis degree | Left main coronary artery | Pathology


name: Stenosis degree | Mid left anterior descending artery | Pathology


name: Stenosis degree | Mid right coronary artery | Pathology


name: Stenosis degree | Middle left circumflex artery | Pathology


name: Stenosis degree | Proximal left anterior descending artery | Pathology


name: Stenosis degree | Proximal left circumflex artery | Pathology


name: Stenosis degree | Proximal right coronary artery | Pathology


name: Depth of stromal invasion/Cervical thickness | Endometrial cancer specimen | Pathology


name: Thickness | Heart interventricular septum | Pathology


name: Thickness | Heart ventricle - left | Pathology


name: Thickness | Heart.ventricle Right | Pathology


name: Volume | Pleural space Right | Pathology


name: PD-L1 by clone SP263 | Tissue and Smears | Pathology


name: Atypical crystals | Urine sediment | Urinalysis


name: Hyaline-granular casts | Urine sediment | Urinalysis


name: Microorganism casts | Urine sediment | Urinalysis


name: Interferon.beta 1 Ab.Neut | Serum or Plasma | Serology - non-micro


name: Adalimumab and Adalimumab Ab panel | Serum or Plasma | Serology Panels


name: Dysautonomia autoimmune Ab panel | Serum | Serology Panels


name: Collection supervision level | Specimen | Specimen information


name: Time received in laboratory | Specimen | Specimen information


name: Vendor model number | Pacemaker | Devices


name: Vendor model number | Pacemaker lead | Devices


name: Vendor serial number | Pacemaker | Devices


name: Vendor serial number | Pacemaker lead | Devices


name: Arrival notification note | Emergency department | Document ontology


name: Departure notification note | Emergency department | Document ontology


name: Pacing interval | Pacemaker | EKG measurements


name: Cardiac implantable loop monitor study | Heart | Cardiac procedures


name: Cardiac 2D echo panel | Heart | Cardiac Panels


name: Optical coherence tomography study | Retina | Ophthalmic optical coherence tomography


name: Eye that was covered with red lens during test | Eye | Eye physical exam


name: Phoria exam method | Eye | Eye physical exam


name: Room brightness level during testing | Eye | Eye physical exam


name: Worth 4 dot test far | Eye | Eye physical exam


name: Worth 4 dot test near | Eye | Eye physical exam


name: Accommodation using minus lens | Eye | Refraction


name: Add for binocular accommodative lag | Left eye | Refraction


name: Add for binocular accommodative lag | Right eye | Refraction


name: Add for monocular accommodative lag | Left eye | Refraction


name: Add for monocular accommodative lag | Right eye | Refraction


name: Threshold angle for measuring depth perception | Eye | Refraction


name: Far convergence break | Eye | Refraction


name: Far convergence recovery | Eye | Refraction


name: Far divergence recovery | Eye | Refraction


name: Eye for far infravergence measurement | Patient | Refraction


name: Far infravergence break | Eye | Refraction


name: Far infravergence recovery | Eye | Refraction


name: Eye for far supravergence measurement | Patient | Refraction


name: Far supravergence break | Eye | Refraction


name: Far supravergence recovery | Eye | Refraction


name: Meter angle for near point convergence | Eye | Refraction


name: Near convergence blur | Eye | Refraction


name: Near convergence break | Eye | Refraction


name: Near convergence recovery | Eye | Refraction


name: Near divergence break | Eye | Refraction


name: Near divergence recovery | Eye | Refraction


name: Eye for near infravergence measurement | Eye | Refraction


name: Near infravergence break | Eye | Refraction


name: Near infravergence recovery | Eye | Refraction


name: Eye for near supravergence measurement | Eye | Refraction


name: Near supravergence break | Eye | Refraction


name: Near supravergence recovery | Eye | Refraction


name: Eye that sees the larger image in horizontal aniseikonia | Patient | Refraction


name: Eye that sees the larger image in vertical aniseikonia | Patient | Refraction


name: Horizontal prism - in far for Percival | Eye | Refraction


name: Horizontal prism - in far for Sheard | Eye | Refraction


name: Horizontal prism - in for binocular accommodative lag | Left eye | Refraction


name: Horizontal prism - in for binocular accommodative lag | Right eye | Refraction


name: Horizontal prism - in for far fixation disparity | Left eye | Refraction


name: Horizontal prism - in for far fixation disparity | Right eye | Refraction


name: Horizontal prism - in for far phoria | Left eye | Refraction


name: Horizontal prism - in for far phoria | Right eye | Refraction


name: Horizontal prism - in for monocular accommodative lag | Left eye | Refraction


name: Horizontal prism - in for monocular accommodative lag | Right eye | Refraction


name: Horizontal prism - in for near fixation disparity | Left eye | Refraction


name: Horizontal prism - in for near fixation disparity | Right eye | Refraction


name: Horizontal prism - in for near phoria | Left eye | Refraction


name: Horizontal prism - in for near phoria | Right eye | Refraction


name: Horizontal prism - in near for Percival | Eye | Refraction


name: Horizontal prism - in near for Sheard | Eye | Refraction


name: Horizontal prism - out far for Percival | Eye | Refraction


name: Horizontal prism - out far for Sheard | Eye | Refraction


name: Horizontal prism - out for binocular accommodative lag | Left eye | Refraction


name: Horizontal prism - out for binocular accommodative lag | Right eye | Refraction


name: Horizontal prism - out for far fixation disparity | Left eye | Refraction


name: Horizontal prism - out for far fixation disparity | Right eye | Refraction


name: Horizontal prism - out for far phoria | Left eye | Refraction


name: Horizontal prism - out for far phoria | Right eye | Refraction


name: Horizontal prism - out for monocular accommodative lag | Left eye | Refraction


name: Horizontal prism - out for monocular accommodative lag | Right eye | Refraction


name: Horizontal prism - out for near fixation disparity | Left eye | Refraction


name: Horizontal prism - out for near fixation disparity | Right eye | Refraction


name: Horizontal prism - out for near phoria | Left eye | Refraction


name: Horizontal prism - out for near phoria | Right eye | Refraction


name: Horizontal prism - out near for Percival | Eye | Refraction


name: Horizontal prism - out near for Sheard | Eye | Refraction


name: Lens used for testing | Eye | Refraction


name: Minimum stereopsis angle | Eye | Refraction


name: Negative relative accommodation blur | Eye | Refraction


name: Negative relative accommodation recovery | Eye | Refraction


name: Positive relative accommodation blur | Eye | Refraction


name: Positive relative accommodation recovery | Eye | Refraction


name: Prism base direction for far fixation disparity | Left eye | Refraction


name: Prism base direction for far fixation disparity | Right eye | Refraction


name: Prism base direction for far phoria | Left eye | Refraction


name: Prism base direction for far phoria | Right eye | Refraction


name: Prism base direction for near fixation disparity | Left eye | Refraction


name: Prism base direction for near fixation disparity | Right eye | Refraction


name: Prism base direction for near phoria | Left eye | Refraction


name: Prism base direction for near phoria | Right eye | Refraction


name: Prism for far fixation disparity | Left eye | Refraction


name: Prism for far fixation disparity | Right eye | Refraction


name: Prism for far phoria | Left eye | Refraction


name: Prism for far phoria | Right eye | Refraction


name: Prism for near fixation disparity | Left eye | Refraction


name: Prism for near fixation disparity | Right eye | Refraction


name: Prism for near phoria | Left eye | Refraction


name: Prism for near phoria | Right eye | Refraction


name: Prism for near point accommodation | Eye | Refraction


name: Prism for near point accommodation | Left eye | Refraction


name: Prism for near point accommodation | Right eye | Refraction


name: Prism for near point convergence | Eye | Refraction


name: Sphere far for Percival | Eye | Refraction


name: Sphere far for Sheard | Eye | Refraction


name: Sphere intermediate | Left eye | Refraction


name: Sphere intermediate | Right eye | Refraction


name: Sphere near for Percival | Eye | Refraction


name: Sphere near for Sheard | Eye | Refraction


name: Vertical prism - down for far fixation disparity | Left eye | Refraction


name: Vertical prism - down for far fixation disparity | Right eye | Refraction


name: Vertical prism - down for far phoria | Left eye | Refraction


name: Vertical prism - down for far phoria | Right eye | Refraction


name: Vertical prism - down for near fixation disparity | Left eye | Refraction


name: Vertical prism - down for near fixation disparity | Right eye | Refraction


name: Vertical prism - down for near phoria | Left eye | Refraction


name: Vertical prism - down for near phoria | Right eye | Refraction


name: Vertical prism - up for far fixation disparity | Left eye | Refraction


name: Vertical prism - up for far fixation disparity | Right eye | Refraction


name: Vertical prism - up for far phoria | Left eye | Refraction


name: Vertical prism - up for far phoria | Right eye | Refraction


name: Vertical prism - up for near fixation disparity | Left eye | Refraction


name: Vertical prism - up for near fixation disparity | Right eye | Refraction


name: Vertical prism - up for near phoria | Left eye | Refraction


name: Vertical prism - up for near phoria | Right eye | Refraction


name: Phoropter panel | Eye | Ophthalmic panels


name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome


name: Energizer Max Alkaline Button Top Batteries


name: Energizer Max Alkaline E93BP-2 Batteries


name: Energizer Max Alkaline E95BP-2 Batteries


name: Hydrating Mineral Sunscreen SPF 30 Lotion


name: Hydrating Mineral Sunscreen SPF 50 Lotion


name: Johnson & Johnson All Purpose First Aid Kit


name: Johnson & Johnson Band Aid Kling Rolled Gauze


name: Omron 3 Series Wrist Blood Pressure Monitor


name: Omron 7 Series Wrist Blood Pressure Monitor


name: Omron Evolv Upper Arm Blood Pressure Monitor


name: AXE Dry Anti-Perspirant & Deodorant, Kilo


name: AXE Dry Antiperspirant & Deodorant, Phoenix


name: AutoSoft XC Infusion Set, 6 mm Cannula, Blue


name: Autosoft XC Infusion Set, 9mm Cannula, Grey


name: Baby SPF 50 Mineral Sunscreen Face Stick


name: Banana Boat Kids Sunscreen Spray, SPF 50


name: Band Aid First Aid Flexible Rolled Gauze


name: Band-Aid Antibiotic With Neosporin Bandages


name: Band-Aid Bandages Finding Dory Assorted Sizes


name: Band-Aid Brand Adhesive Bandages Tough Strips


name: Band-Aid Brand Adhesive Bandages Variety Pack


name: Band-Aid Brand Cushion Care Gauze Pads, Small


name: Band-Aid Brand Cushion Care, Small, White


name: Band-Aid Brand Water Block Flex Adhesive Pads


name: Band-Aid Cushion Care Adhesive Gauze Pad


name: Band-Aid Disney Pixar Incredibles 2 Bandages


name: Band-Aid First Aid Hurt Free Wrap, Medium


name: Band-Aid Flexible Fabric Adhesive Bandages


name: Band-Aid Hydro Seal All-Purpose Bandages


name: Band-Aid Hydro Seal Blister Cushions Bandages


name: Band-Aid Hydro Seal Blister Heels Bandages


name: Band-Aid Hydro Seal Hydrocolloid Gel Bandages


name: Band-Aid Infection Defense Adhesive Cover


name: Band-Aid Infection Defense Neosporin Bandages


name: Band-Aid Nickelodeon Paw Patrol Bandages


name: Band-Aid Water Block Flex Adhesive Bandages


name: Blue Lizard Sunscreen Lotion Baby, SPF 50+


name: Blue Lizard Sunscreen Sensitive Skin SPF 50+


name: Cetaphil Cleansing Cloths For Sensitive Skin


name: Colgate Max Clean With Whitening Toothpaste


name: Colgate Max Fresh With Whitening Toothpaste


name: Contour Next EZ Blood Glucose Monitoring


name: Coppertone Defend & Care Clear Zinc SPF 50


name: Coppertone Defend & Care Face Oil Free SPF 30


name: Coppertone Defend & Care Face Oil Free SPF 50


name: Coppertone Defend & Care Face Stick SPF 50


name: Coppertone Defend & Care Sunscreen SPF 50


name: Coppertone Defend &Care Face Sunscreen SPF 50


name: Coppertone Defend &Care Ultra Hydrate SPF 50


name: Coppertone Pure & Simple Baby Lotion SPF 50


name: Coppertone Pure & Simple Baby Stick SPF 50


name: Coppertone Pure & Simple Face Lotion SPF 50


name: Coppertone Pure & Simple Kids Lotion SPF 50


name: Coppertone Sport Face Sunscreen Lotion SPF 50


name: Coppertone Sport Sunscreen Lotion SPF 100


name: Coppertone Sport Sunscreen Lotion SPF 15


name: Coppertone Sport Sunscreen Lotion SPF 30


name: Coppertone Sport Sunscreen Lotion SPF 50


name: Coppertone Sport Sunscreen Lotion SPF 70


name: Coppertone Sport Sunscreen Spray SPF 100


name: Coppertone Sport Sunscreen Twin Pack SPF 30


name: Coppertone Sport Sunscreen Twin Pack SPF 50


name: Coppertone Tanning Sunscreen Spray SPF 15


name: Coppertone Ultra Guard Sunscreen Spray SPF 50


name: Coppertone Water Babies Lotion Spray SPF 50


name: Coppertone Water Babies Sunscreen SPF 50


name: Coppertone Water Babies Twin Pack SPF 50


name: Energizer EZ Turn & Lock Hearing Aid Battery


name: Energizer Max 522-BP 9V Alkaline Battery


name: Lotion, Multi Ingredient Topical application Lotion [Leader Baby Lotion]


name: Formula, Infant Oral Powder for Suspension [Enfagrow Premium Toddler Gentlease]


name: Bupivacaine Hydrochloride;Isopropyl Alcohol;Lidocaine Hydrochloride;Methylprednisolone Acetate;Povidone Iodine 0.25%; 70%; 1%; 80 MG/1 ML; 10% Multiple Routes Kit


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL TOPICAL LOTION [Royal Boost Cover Me Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 90 mg in 1 mL / OCTOCRYLENE 65 mg in 1 mL TOPICAL CREAM [CLARINS - EXTRA-FIRMING JOUR SPF 15 - Wrinkle, Firming Day all skin types - Broad Spectrum SPF 15 Sunscreen]


name: OCTISALATE 4.5 g in 50 mL / HOMOSALATE 9 g in 50 mL / AVOBENZONE 2.7 g in 50 mL / OCTOCRYLENE 9 g in 50 mL TOPICAL LOTION [ISA KNOX ANEW SOLAIRE ACTIVE FACE AND BODY PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN]


name: TITANIUM DIOXIDE 3.5 g in 100 g / ZINC OXIDE 16.9 g in 100 g TOPICAL STICK [Bare Republic Big Adventure Stick SPF 70]


name: ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY 17 g in 100 g TOPICAL STICK [Old Spice Playmaker High Endurance]


name: GENTAMICIN SULFATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 206 mg in 1 mL TOPICAL SPRAY [Babo Botanicals Sensitive Baby Fragrance Free Diaper Rash]


name: ZINC OXIDE 3 g in 100 mL / OCTINOXATE 6 g in 100 mL TOPICAL LOTION [Olay Complete UV365 Daily Moisturizer Sensitive Broad Spectrum SPF 15]


name: OCTISALATE 4.5 g in 50 mL / HOMOSALATE 7 g in 50 mL / AVOBENZONE 2.7 g in 50 mL / OCTOCRYLENE 9 g in 50 mL TOPICAL CREAM [ISA KNOX LXNEW PLATINUM SCULPTING DAY BROAD SPECTRUM SPF 30 SUNSCREEN]


name: ZINC OXIDE 175 mg in 1 mL TOPICAL CREAM [YAYA Organics SPF-50 Baby Kids Mineral Sunscreen]


name: PREDNISOLONE ACETATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 175 mg in 1 mL TOPICAL CREAM [YAYA Organics SPF-50 Sports Cream]


name: DIMETHICONE 2 g in 100 g TOPICAL STICK [Royal Jelly Berry Powerful Lip Care]


name: OCTISALATE 2.5 mg in 50 mL / AVOBENZONE 1.5 mg in 50 mL / HOMOSALATE 7.5 mg in 50 mL TOPICAL LOTION [Dermatouch Hydrating Clear Moisutrizer SPF 25]


name: OCTINOXATE 5.6 g in 100 mL / OCTOCRYLENE 7.5 g in 100 mL / ZINC OXIDE 4.8 g in 100 mL TOPICAL CREAM [First Aid Beauty FAB Broad Spectrum Sunscreen SPF 30]


name: OCTINOXATE 67 mg in 1 mL / TITANIUM DIOXIDE 36 mg in 1 mL TOPICAL LIQUID [LOreal Paris Infallible Up to 24 H Fresh Wear Foundation Broad Spectrum SPF 25 Sunscreen]


name: OCTINOXATE 68 mg in 1 mL TOPICAL LOTION [Giorgio Armani Power Fabric Plus Weightless Matte Foundation Broad Spectrum SPF 25 Sunscreen]


name: OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 6 g in 100 mL / AVOBENZONE 3 g in 100 mL / HOMOSALATE 9 g in 100 mL TOPICAL CREAM [Olay Regenerist Vitamin C plus Peptide 24 Hydrating Moisturizer with Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 10.5 g in 100 g / HOMOSALATE 10 g in 100 g TOPICAL CREAM [silk SPF facial sunscreen fluid hybrid broad spectrum SPF 30 UVA/UVB]


name: ALUMINUM CHLOROHYDRATE 20 g in 100 g TOPICAL STICK [CLARISSE ANTIPERSPIRANT DEODORANRT CHERRY BLOSSOM]


name: ALUMINUM CHLOROHYDRATE 20 g in 100 g TOPICAL STICK [LUCKY ANTIPERSPIRANT DEODORANT EXTREME ENERGY]


name: TITANIUM DIOXIDE 2.3 g in 100 mL / ZINC OXIDE 17.9 g in 100 mL TOPICAL LOTION [100% Mineral Broad Spectrum Sunscreen SPF 50]


name: ZINC OXIDE 16 g in 100 mL TOPICAL LOTION [100% Mineral Broad Spectrum Sunscreen SPF 30]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL LOTION [CLEAR GLOW RADIANT SUN SERUM SPF50]


name: OCTINOXATE 7.5 g in 1 mL / OCTOCRYLENE 2.2 mg in 1 mL / OCTISALATE 5 mg in 1 mL / AVOBENZONE 2 mg in 1 mL / OXYBENZONE 5 mg in 1 mL TOPICAL LOTION [Prevage anti aging SPF 30]


name: OXYBENZONE 4 mg in 1 g / OCTINOXATE 7.5 mg in 1 g / OCTOCRYLENE 3 mg in 1 g / AVOBENZONE 2 mg in 1 g / OCTISALATE 5 mg in 1 g TOPICAL EMULSION [CERAMIDE PREMIERE BROAD SPECTRUM SPF 30]


name: TITANIUM DIOXIDE 6.97 mg in 1 mL / ZINC OXIDE 4.99 mg in 1 mL / HOMOSALATE 6 mg in 1 mL / OCTISALATE 3 mg in 1 mL / OCTOCRYLENE 2.4 mg in 1 mL TOPICAL EMULSION [Revlon Colorstay Light Cover Foundation]


name: ZINC OXIDE 5.6 mg in 1 g / TITANIUM DIOXIDE 6.2 mg in 1 g TOPICAL EMULSION [PREVAGE CITY SMART]


name: IODINE 578 mg in 1 mL NOT APPLICABLE SOLUTION [Iodine 260 Premix]


name: OXYBENZONE 1.4 mg in 1 g / OCTINOXATE 4.1 mg in 1 g TOPICAL CREAM [Prevage Anti-aging eye cream SPF 15]


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [Attitude tinted mineral sunscreen face unscented SPF 30]


name: ALUMINUM CHLOROHYDRATE 15 g in 100 g TOPICAL SOLUTION [On-the-go Underarm Antiperspirant Wipes]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL SOLUTION [Underarm Antiperspirant PM Wipes Clean Lavender Scent]


name: TIROFIBAN HYDROCHLORIDE 0.25 mg in 1 mL NOT APPLICABLE INJECTION


name: ZINC OXIDE 120 mg in 1 mL TOPICAL CREAM [KISS MY FACE SPF-50 Baby Mineral Sunscreen]


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [Attitude Kids mineral sunscreen tropical SPF 30]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [JOYSPRING Kids Mineral Sunscreen SPF-30]


name: ZINC OXIDE 20 g in 100 g TOPICAL CREAM [Attitude mineral sunscreen tropical SPF 30]


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [Attitude Kids mineral sunscreen unscented SPF 30]


name: OCTINOXATE 3 g in 100 mL / ZINC OXIDE 6.8 g in 100 mL TOPICAL LIQUID [Radiance Foundation Broad Spectrum SPF 20 - Tawny]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL CREAM [EIGHT SAINTS Chase The Sun SPF-30]


name: ZINC OXIDE 20 g in 100 g TOPICAL CREAM [Attitude Kids Oatmeal sensitive mineral sunscreen unscented SPF 30]


name: TITANIUM DIOXIDE 100 mg in 1 mL / ZINC OXIDE 100 mg in 1 mL TOPICAL CREAM [Aruba Aloe SPF 50 Mineral Sunscreen BABIES]


name: TITANIUM DIOXIDE 80 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL CREAM [Aruba Aloe SPF 30 Mineral Sunscreen]


name: Titanium Dioxide 110 mg in 1 mL TOPICAL LOTION [Nu Colour Bioadaptive BB Plus Foundation - Almond]


name: Titanium Dioxide 50 mg in 1 mL TOPICAL LOTION [Nu Colour Bioadaptive BB Plus Foundation - Espresso]


name: Titanium Dioxide 80 mg in 1 mL TOPICAL LOTION [Nu Colour Bioadaptive BB Plus Foundation - Chestnut]


name: Titanium Dioxide 90 mg in 1 mL TOPICAL LOTION [Nu Colour Bioadaptive BB plus Foundation - Mocha]


name: ZINC OXIDE 20 g in 100 g TOPICAL CREAM [Attitude Kids mineral sunscreen unscented SPF 30]


name: Zinc Oxide 6 g in 100 mL TOPICAL LOTION [Method Men Face with Zinc Oxide Sunscreen]


name: Titanium Dioxide 120 mg in 1 mL TOPICAL LOTION [Nu Colour Bioadaptive BB Plus Foundation - Ivory]


name: Titanium Dioxide 130 mg in 1 mL TOPICAL LOTION [Nu Colour Bioadaptive BB plus Foundation - Beige]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [TIGER BABY Baby Sunscreen SPF-50]


name: PRAZIQUANTEL 1 kg in 1 kg NOT APPLICABLE POWDER


name: Niacinamide 2.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL CREAM [BonGin Rebalancing GIN]


name: Niacinamide 2.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL EMULSION [BonGin Rebalancing GIN]


name: Niacinamide 2.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL LIQUID [BonGin Revitalizing GIN Water]


name: Niacinamide 2.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL PATCH [BonGin BonCell Rejuvenating Mask Pack]


name: Niacinamide 3.0 g in 100 mL / Adenosine 1.20 g in 100 mL TOPICAL LIQUID [BonGin BonCell ECM Boost 195 HA]


name: HOMOSALATE 85 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 85 mg in 1 mL / ZINC OXIDE 121 mg in 1 mL TOPICAL LOTION [WATERMELON GLOW NIACINAMIDE SUNSCREEN]


name: METRONIDAZOLE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 200 mg in 1 g TOPICAL LOTION [Tinted Mineral Sunscreen Broad Spectrum SPF 25]


name: ZINC OXIDE 250 mg in 1 g TOPICAL LOTION [Tinted Mineral Sunscreen Broad Spectrum SPF 40]


name: Aluminum Sesquichlorohydrate 0.15 kg in 1 kg TOPICAL Lotion [Carpe Antiperspirant Underarm Fresh Powder Scent]


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 8 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g TOPICAL LOTION [Coppertone Sunscreen SPF 50]


name: OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g / OCTOCRYLENE 10 g in 100 g / HOMOSALATE 15 g in 100 g TOPICAL LOTION [Aruba Sun SPF 50 Sunscreen]


name: OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g / OCTOCRYLENE 6 g in 100 g / HOMOSALATE 15 g in 100 g TOPICAL LOTION [Aruba Sun SPF 30 Sunscreen]


name: CHLOROQUINE DIPHOSPHATE, (R)- 1 kg in 1 kg NOT APPLICABLE POWDER


name: NALIDIXIC ACID 1 kg in 1 kg NOT APPLICABLE POWDER


name: {1 (30 ML) (salicylic acid 10 MG/ML Medicated Liquid Soap) / 1 (30 ML) (salicylic acid 10 MG/ML Topical Cream) } Pack


name: nutritional therapy for phenylketonuria(PKU) with iron no.52 60 gram-306 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: insulin pump cartridge,continuous subcut infusion,bluetooth SUBCUT CARTRIDGE (EA)


name: insulin pump cartridge,continuous subcut infusion,radio freq SUBCUT CARTRIDGE (EA)


name: nutritional therapy for phenylketonuria(PKU) with iron no.52 60 gram-316 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for tyrosinemia with iron 60 gram-316 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: insulin pump cartridge, cont subcut inf, bluetooth


name: insulin pump cartridge,cont subcut,radio frequency


name: CATHETER,LOFRIC PRIMO14FR WELLSPECT #4141440


name: UNDERPAD,FLUFF-FILLED 23IN X 24IN #MSC281241


name: DRESSING,TEGADERM CHG IV 3.5IN X 4.5IN W/DEVICE


name: SET,INFUSION 20GA 1IN SMITHS #21-3466-24


name: DRESSING,MEDLINE ISLAND 4IN X 10IN #MSC32410


name: CATHETER,INTERMITTENT 14FR CURE #ULTRAM14


name: DRESSING,MEPILEX BORDER FLEX LITE 4IN X 4IN #581300


name: DRESSING,ECLYPSE SUPER ABSORBENT #CR3743


name: DRESSING,OPTICELL 4.25IN X 4.25IN MEDLINE #MSC7844EP


name: DRESSING,MEPILEX BORDER FLEX LITE 1.6IN X 2IN #581011


name: CATHETER,SUCTION,6FR KIT CARDINAL HEALTH #ZRSCK6


name: DRESSING,MEPILEX BORDER FLEX LITE 3IN X 3IN #581200


name: DRESSING,MEPILEX LITE 8IN X 20IN #284599


name: SET,INFUSION,EXTENSION SMALL BORE BRAUN #473445


name: STOPCOCK,SMALL BORE,4-WAY SMITHS #MX5341L


name: Suspected infection caused by novel Influenza A virus variant


name: Referral for anticoagulant therapy management


name: Referral for housing repair assessment program


name: Evaluation of eligibility for housing repair program


name: Assistance with application for housing repair program


name: Referral to emergency housing fund program


name: Evaluation of eligibility for taxi voucher program


name: Assistance with application for taxi voucher program


name: Evaluation of eligibility for vehicle donation program


name: Education about vehicle donation program


name: Assistance with application for vehicle donation program


name: Referral to transportation network company program


name: Assistance with application for transportation network company program


name: Evaluation of eligibility for ride hailing program


name: Assistance with application for ride hailing program


name: Education about transportation network company program


name: Evaluation of eligibility for transportation network company program


name: Referral to public transportation voucher program


name: Referral to Medicaid transportation program


name: Assistance with application for vehicle share program


name: Assistance with application for bicycle share program


name: Victim of physical abuse by intimate partner


name: Victim of emotional abuse by intimate partner


name: Suspected victim of abuse by intimate partner


name: Suspected victim of emotional abuse by intimate partner


name: Suspected victim of sexual abuse by intimate partner


name: Suspected victim of physical abuse by intimate partner


name: History of intimate partner physical abuse


name: History of intimate partner sexual abuse


name: History of intimate partner emotional abuse


name: History of victim of elder financial abuse


name: History of victim of elder emotional abuse


name: Suspected victim of elder financial abuse


name: Transportation insecurity due to unsafe transportation environment


name: Transportation insecurity due to excessive travel time to destination


name: Transportation insecurity due to no driver's license


name: Inability to access health care due to transportation insecurity


name: Transportation insecurity due to no access to vehicle


name: Inability to access community resources due to transportation insecurity


name: Transportation insecurity due to unaffordable transportation


name: Suppression of microbiota of gastrointestinal tract caused by antibiotic


name: Referral to hearing assistive technology service


name: The service was furnished using audio-only communication technology


name: The supervising practitioner was present through two-way, audio/video communication technology


name: Split (or shared) evaluation and management visit


name: Unrelated evaluation and management (e/m) visit on the same day as another e/m visit or during a global procedure (preoperative, postoperative period, or on the same day as the procedure, as applicable). (report when an e/m visit is furnished within the global period but is unrelated, or when one or more additional e/m visits furnished on the same day are unrelated)


name: Innovamatrix ac, per square centimeter (add-on, list separately in addition to primary procedure)


name: Mirragen advanced wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Microlyte matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Novosorb synpath dermal matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Restrata, per square centimeter (add-on, list separately in addition to primary procedure)


name: Theragenesis, per square centimeter (add-on, list separately in addition to primary procedure)


name: Symphony, per square centimeter (add-on, list separately in addition to primary procedure)


name: Apis, per square centimeter (add-on, list separately in addition to primary procedure)


name: Irrigation supply; sleeve, reusable, per month


name: Irrigation supply; sleeve, disposable, per month


name: Rectal catheter with or without balloon, for use with any type transanal irrigation system, each


name: Interbody cage, anterior, lateral or posterior, personalized (implantable)


name: Autograft suspension, including cell processing and application, and all system components


name: Monitor, cardiac, including intracardiac lead and all system components (implantable)


name: Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)


name: Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy


name: Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)


name: Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed


name: Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance


name: Tablo hemodialysis system for the billable dialysis service


name: Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period (G0029)


name: Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user (G0030)


name: Two or more antipsychotic prescriptions ordered for patients who had a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between january 1 of the year prior to the measurement period and the index prescription start date (ipsd) for antipsychotics


name: Two or more benzodiazepine prescriptions ordered for patients who had a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between january 1 of the year prior to the measurement period and the ipsd for benzodiazepines


name: Patient has any emergency department encounter during the performance period with place of service indicator 23


name: Patient or care partner decline assessment


name: On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available


name: Clinician determines patient does not require referral


name: Patient not referred, reason not otherwise specified


name: Patient already receiving physical/occupational/speech/recreational therapy during the measurement period


name: Patient and/or care partner decline referral


name: Referral to physical, occupational, speech, or recreational therapy


name: Patients with mechanical prosthetic heart valve


name: Patients with moderate or severe mitral stenosis


name: Clinical follow-up and mrs score assessed at 90 days following endovascular stroke intervention


name: Clinical follow-up and mrs score not assessed at 90 days following endovascular stroke intervention


name: Pediatric patient with minor blunt head trauma and pecarn prediction criteria are not assessed


name: With maintenance hemodialysis (in-center and home hd) for the complete reporting month


name: Patients with a catheter that have limited life expectancy


name: Patients under hospice care in the current reporting month


name: Patients on peritoneal dialysis for any portion of the reporting month


name: Advancing rheumatology patient care mips value pathways


name: Coordinating stroke care to promote prevention and cultivate positive outcomes mips value pathways


name: Advancing care for heart disease mips value pathways


name: Proposed adopting best practices and promoting patient safety within emergency medicine mips value pathways


name: Improving care for lower extremity joint repair mips value pathways


name: Patient safety and support of positive experiences with anesthesia mips value pathways


name: Certified nurse midwife mips specialty set


name: Chiropractic medicine mips specialty set


name: Colorectal cancer screening; blood-based biomarker


name: Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment


name: Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)


name: Patient-months where there are more than one medicare capitated payment (mcp) provider listed for the month


name: The number of adult patient-months in the denominator who were on maintenance hemodialysis using a catheter continuously for three months or longer under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month


name: The number of adult patient-months in the denominator who were on maintenance hemodialysis under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month using a catheter continuously for less than three months


name: Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure


name: Services for high intensity clinical services associated with the initial engagement and outreach of beneficiaries assigned to the sip component of the pcf model (do not bill with chronic care management codes)


name: All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project


name: Electrophysiology cardiac specialist mips specialty set


name: Interventional radiology mips specialty set


name: Mental/behavioral and psychiatry mips specialty set


name: Obstetrics/gynecology mips specialty set


name: Ophthalmology/optometry mips specialty set


name: Physical therapy/occupational therapy mips specialty set


name: Skilled nursing facility mips specialty set


name: Speech language pathology mips specialty set


name: Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, less than 10 minutes


name: Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, 10-20 minutes


name: Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, more than 20 minutes


name: Documentation stating the patient has received or is currently receiving palliative or hospice care (G9996)


name: Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter (G9997)


name: Documentation of medical reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., last colonoscopy incomplete, last colonoscopy had inadequate prep, piecemeal removal of adenomas, or sessile serrated polyps >= 20 mm in size, last colonoscopy found greater than 10 adenomas, lower gastrointestinal bleeding, or patient at high risk for colon cancer due to underlying medical history ([i.e. crohn's disease, ulcerative colitis, personal or family history of colon cancer, hereditary colorectal cancer syndromes])


name: Documentation of system reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., unable to locate previous colonoscopy report, patient cannot provide precise date or details from previous colonoscopy, previous colonoscopy report was incomplete)


name: Enema tube, with or without adapter, any type, replacement only, each


name: Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control


name: Foot, adductus positioning device, adjustable


name: Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve


name: External upper limb tremor stimulator of the peripheral nerves of the wrist


name: Exsufflation belt, includes all supplies and accessories


name: Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type


name: Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm


name: Non-pneumatic compression controller with sequential calibrated gradient pressure


name: Non-pneumatic sequential compression garment, full arm


name: Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical


name: Oral device/appliance used to reduce upper airway collapsibility, without fixed mechanical hinge, custom fabricated, includes fitting and adjustment


name: Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose


name: Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose


name: Plasma, cryoprecipitate reduced, pathogen reduced, each unit


name: Cryoprecipitated fibrinogen complex, pathogen reduced, each unit


name: Cygnus matrix, per square centimeter (add-on, list separately in addition to primary procedure)


name: Vim, per square centimeter (add-on, list separately in addition to primary procedure)


name: Vendaje, per square centimeter (add-on, list separately in addition to primary procedure)


name: Zenith amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)


name: Department of veterans affairs whole health partner services


name: Stent, non-coronary, temporary, with delivery system (propel)


name: Medical foods for non-inborn errors of metabolism


name: {7 (mitapivat 20 MG Oral Tablet [Pyrukynd]) / 7 (mitapivat 50 MG Oral Tablet [Pyrukynd]) } Pack [Pyrukynd 20 MG / 50 MG Taper]


name: Impairment of integrity of oral mucous membrane


name: Resection of femoral head and neck of femur


name: Pharyngeal reconstruction by direct closure


name: Closed treatment of nasal bone fracture with manipulation; without stabilization


name: Injection of sclerosant; single incompetent vein (other than telangiectasia)


name: choroidal neovascularization (physical finding)


name: Benzoyl Peroxide;Benzoyl Peroxide 5%; 8% Multiple Routes Soap


name: Lipid panel This panel must include the following: Cholesterol, serum, total (82465) Lipoprotein, direct measurement, high density cholesterol (HDL cholesterol) (83718) Triglycerides (84478)


name: FRAGILE SITE, DISTAMYCIN A TYPE, RARE, FRA(16)(p12.1)


name: Epidermal growth factor receptor inhibitor


name: Miconazole Nitrate 2% Topical application Kit


name: {18 (oteseconazole 150 MG Oral Capsule [Vivjoa]) } Pack [Vivjoa 18-Count]


name: Anti-islet antigen-2 antibody positivity


name: laser vaporization of prostate for urine flow


name: Deficiency of Zeta-chain associated protein kinase 70


name: 11 Beta-Hydroxysteroid Dehydrogenase Type 2 Deficiency


name: Repair of tendon of hand by transfer or transplantation


name: FXN (frataxin) (eg, Friedreich ataxia), gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions


name: maternal substance abuse during pregnancy


name: United States of America English language reference set (foundation metadata concept)


name: {7 (mitapivat 5 MG Oral Tablet [Pyrukynd]) } Pack [Pyrukynd 5 MG Taper]


name: {56 (mitapivat 5 MG Oral Tablet [Pyrukynd]) } Pack [Pyrukynd 5 MG 4-Week]


name: Maternal Substance Abuse during Pregnancy question


name: {10 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack [Paxlovid 150 MG /100 MG Dose Pack]


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Capsule) / 4 (ferrous fumarate 75 MG Oral Capsule) } Pack [Merzee 28 Day]


name: {1 (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack


name: Conventional release dental cement (dose form)